Likewise, the women from our study diagnosed with mixed thrombophilia tested positive in 3.95% of the cases for the homozygote form of ACE_insertion_deletion mutation (angiotensin converting enzyme gene), which was demonstrated to increase miscarriage risk in European women [20,21]. The gene discussed is ACE; the disease is thrombophilia.